![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: INTS5 |
Gene summary for INTS5 |
![]() |
Gene information | Species | Human | Gene symbol | INTS5 | Gene ID | 80789 |
Gene name | integrator complex subunit 5 | |
Gene Alias | INT5 | |
Cytomap | 11q12.3 | |
Gene Type | protein-coding | GO ID | GO:0006139 | UniProtAcc | Q6P9B9 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
80789 | INTS5 | LZE4T | Human | Esophagus | ESCC | 2.61e-02 | 5.39e-02 | 0.0811 |
80789 | INTS5 | LZE20T | Human | Esophagus | ESCC | 2.56e-02 | 8.51e-02 | 0.0662 |
80789 | INTS5 | LZE24T | Human | Esophagus | ESCC | 7.22e-09 | 2.78e-01 | 0.0596 |
80789 | INTS5 | P2T-E | Human | Esophagus | ESCC | 1.99e-10 | 1.60e-01 | 0.1177 |
80789 | INTS5 | P4T-E | Human | Esophagus | ESCC | 8.22e-13 | 2.40e-01 | 0.1323 |
80789 | INTS5 | P5T-E | Human | Esophagus | ESCC | 1.61e-03 | 2.08e-02 | 0.1327 |
80789 | INTS5 | P8T-E | Human | Esophagus | ESCC | 1.36e-10 | 1.68e-01 | 0.0889 |
80789 | INTS5 | P9T-E | Human | Esophagus | ESCC | 5.33e-07 | 1.10e-01 | 0.1131 |
80789 | INTS5 | P10T-E | Human | Esophagus | ESCC | 5.70e-08 | 4.71e-02 | 0.116 |
80789 | INTS5 | P11T-E | Human | Esophagus | ESCC | 1.64e-05 | 2.06e-01 | 0.1426 |
80789 | INTS5 | P12T-E | Human | Esophagus | ESCC | 1.93e-14 | 2.08e-01 | 0.1122 |
80789 | INTS5 | P15T-E | Human | Esophagus | ESCC | 4.04e-04 | 2.93e-02 | 0.1149 |
80789 | INTS5 | P16T-E | Human | Esophagus | ESCC | 3.63e-08 | 1.22e-01 | 0.1153 |
80789 | INTS5 | P17T-E | Human | Esophagus | ESCC | 1.25e-06 | 1.61e-01 | 0.1278 |
80789 | INTS5 | P20T-E | Human | Esophagus | ESCC | 1.93e-06 | 1.13e-01 | 0.1124 |
80789 | INTS5 | P21T-E | Human | Esophagus | ESCC | 1.11e-07 | 2.62e-01 | 0.1617 |
80789 | INTS5 | P22T-E | Human | Esophagus | ESCC | 1.83e-05 | 7.80e-02 | 0.1236 |
80789 | INTS5 | P23T-E | Human | Esophagus | ESCC | 7.44e-15 | 2.65e-01 | 0.108 |
80789 | INTS5 | P24T-E | Human | Esophagus | ESCC | 1.82e-09 | 1.72e-01 | 0.1287 |
80789 | INTS5 | P26T-E | Human | Esophagus | ESCC | 1.92e-08 | 1.26e-01 | 0.1276 |
Page: 1 2 3 |
![]() |
Tissue | Expression Dynamics | Abbreviation |
Esophagus | ![]() | ESCC: Esophageal squamous cell carcinoma |
HGIN: High-grade intraepithelial neoplasias | ||
LGIN: Low-grade intraepithelial neoplasias |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Liver | Cyst | ![]() |
Lung | IAC | ![]() |
Lung | AIS | ![]() |
Lung | AAH | ![]() |
Lung | MIAC | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:003447015 | Esophagus | ESCC | ncRNA processing | 300/8552 | 395/18723 | 3.09e-35 | 3.26e-32 | 300 |
GO:003466012 | Esophagus | ESCC | ncRNA metabolic process | 346/8552 | 485/18723 | 4.35e-31 | 2.51e-28 | 346 |
GO:00311233 | Esophagus | ESCC | RNA 3'-end processing | 76/8552 | 116/18723 | 1.25e-05 | 1.15e-04 | 76 |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
INTS5 | SNV | Missense_Mutation | novel | c.2017C>T | p.Leu673Phe | p.L673F | Q6P9B9 | protein_coding | deleterious(0.02) | probably_damaging(0.948) | TCGA-A1-A0SP-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | SD | |
INTS5 | SNV | Missense_Mutation | c.3053N>A | p.Gly1018Glu | p.G1018E | Q6P9B9 | protein_coding | deleterious_low_confidence(0) | possibly_damaging(0.897) | TCGA-A8-A07J-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | 5-fluorouracil | CR | |
INTS5 | SNV | Missense_Mutation | novel | c.3049N>A | p.Gln1017Lys | p.Q1017K | Q6P9B9 | protein_coding | tolerated_low_confidence(0.37) | possibly_damaging(0.542) | TCGA-A8-A07U-01 | Breast | breast invasive carcinoma | Female | >=65 | III/IV | Chemotherapy | 5-fluorouracil | SD |
INTS5 | SNV | Missense_Mutation | c.1085N>A | p.Cys362Tyr | p.C362Y | Q6P9B9 | protein_coding | tolerated(0.48) | benign(0.011) | TCGA-A8-A09Z-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
INTS5 | SNV | Missense_Mutation | rs781520641 | c.916G>A | p.Gly306Arg | p.G306R | Q6P9B9 | protein_coding | deleterious(0.02) | possibly_damaging(0.492) | TCGA-B6-A402-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | cyclophosphamide | PD |
INTS5 | insertion | Frame_Shift_Ins | novel | c.2597_2598insGG | p.Ala867ValfsTer45 | p.A867Vfs*45 | Q6P9B9 | protein_coding | TCGA-A2-A0CQ-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | adriamycin | SD | ||
INTS5 | insertion | Frame_Shift_Ins | novel | c.2596_2597insAGAGGCAAAGAAG | p.Ala866GlufsTer35 | p.A866Efs*35 | Q6P9B9 | protein_coding | TCGA-A2-A0CQ-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | adriamycin | SD | ||
INTS5 | insertion | In_Frame_Ins | rs773152337 | c.2597_2598insCTCAGAGAGGCAAAGAAGCGG | p.Ala866_Ala867insSerGluArgGlnArgSerGly | p.A866_A867insSERQRSG | Q6P9B9 | protein_coding | TCGA-A8-A0AB-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | 5-fluorouracil | CR | ||
INTS5 | SNV | Missense_Mutation | c.1269N>C | p.Gln423His | p.Q423H | Q6P9B9 | protein_coding | tolerated(0.06) | benign(0.003) | TCGA-FU-A3TX-01 | Cervix | cervical & endocervical cancer | Female | >=65 | I/II | Unknown | Unknown | SD | |
INTS5 | SNV | Missense_Mutation | rs761220419 | c.2353C>T | p.His785Tyr | p.H785Y | Q6P9B9 | protein_coding | tolerated(0.09) | benign(0) | TCGA-IR-A3LA-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR |
Page: 1 2 3 4 5 6 7 8 9 10 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |